News

Understanding Shareholder Information of Biotalys NV and Its Growth

Understanding Shareholder Information of Biotalys NV and Its Growth

Overview of Biotalys NV's Share Capital and Voting Rights

Biotalys NV, a company headquartered in Ghent, is making significant advancements in the agricultural technology sector. Known for its innovative solutions, Biotalys focuses on biocontrol methods to enhance crop protection during both pre- and post-harvest stages.

Share Capital Breakdown

The share capital of Biotalys NV is established at EUR 5,555,181.05. This figure represents a pivotal component of the company’s financial structure.

Total Voting Securities

As of now, Biotalys has a total of 37,568,645 ordinary shares that possess voting rights. This number underscores the company’s commitment to maintaining shareholder involvement and transparency.

Details of Voting Rights

This number of voting rights reflects the collective power of shareholders to influence company resolutions. Additionally, Biotalys encourages active participation by requiring notifications from any individuals or entities when their voting rights reach or surpass specific thresholds of 5%, 10%, and each multiple of 5% thereafter.

Subscription Rights and Warrants

Biotalys further engages its stakeholders through the issuance of several rights to subscribe for additional securities:

  • 1,779,400 “ESOP Warrants” allow holders to subscribe for 1,779,400 profit certificates, paving the way for eventual conversion into 889,700 voting shares.
  • An additional 1,504,867 “ESOP Warrants” are available, enabling the subscription for the same number of ordinary shares, empowering employees and directors alike.
  • There are 28,653 share units granted as part of the remuneration policy, which includes an obligation for directors to subscribe for new shares at an attractive issue price of one EUR per unit. This strategic move aligns their interests closely with shareholders.

The Absence of Convertible Bonds

It is noteworthy that Biotalys currently holds no outstanding convertible bonds or non-voting shares, indicating a straightforward capital structure that can be advantageous for both the company and its investors.

Innovative Agricultural Solutions

Finding its roots as a spin-off from the Flanders Institute for Biotechnology in 2013, Biotalys continues to expand its portfolio of biocontrol products aimed at pest and disease management across the agricultural value chain. With a strong emphasis on safety and environmental benefits, their AGROBODY™ technology platform positions them as market leaders in the sector.

Market Presence and Future Prospects

As part of the continuous effort to address crucial crop protection needs, Biotalys is actively developing a varied pipeline of product candidates that attract significant attention in both local and international markets. The company’s initiative to balance efficacy with environmental considerations highlights its dedication to sustainable agricultural practices.

This harmonious merge of technology and nature allows Biotalys to offer solutions that not only benefit farmers but also contribute positively to the global ecosystem.

Contact Information

For more insights and inquiries regarding Biotalys NV, please reach out to Toon Musschoot, the Head of Investor Relations and Communication, via telephone at +32 (0)9 274 54 00. Alternatively, you can send an email to IR@biotalys.com.

Frequently Asked Questions

What is Biotalys NV known for?

Biotalys NV specializes in the development of precision biocontrol solutions aimed at enhancing crop protection through environmentally friendly methods.

What is the significance of the share capital?

The share capital illustrates the total financial resources available to the company, reflecting its financial health and investor confidence.

How does Biotalys enhance shareholder engagement?

Through required notifications when voting rights thresholds are crossed, Biotalys ensures that shareholders remain informed and can actively participate in company developments.

What are ESOP Warrants?

ESOP Warrants give holders the right to subscribe to additional shares, which helps align the interests of employees and management with those of shareholders.

What is the AGROBODY™ technology platform?

This innovative technology platform enables Biotalys to create effective biocontrol products, emphasizing both performance and safety in agricultural pest management.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 2

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading

Top 5 Most Recently Viewed Articles

Signing Day Sports Stock Hits Troubling New Low Amid Changes

Updated Category News Views 218

Stock Performance Overview In the midst of a challenging market landscape, Signing Day Sports (SGN) has seen its stock hit a concerning 52-week low, plunging to just $2.15. This drop is alarming and reveals the company's current financial struggles, which are evidenced by a notably weak financial health score and a current ratio of only 0.09. Such numbers suggest...

Continue Reading
Spero Therapeutics Unveils Positive Results for SPR720 Drug Trials

Updated Category News Views 138

Encouraging Outcomes from Spero Therapeutics' SPR720 Trials Spero Therapeutics, Inc. (NASDAQ: SPRO), a biopharmaceutical company devoted to developing treatments for rare diseases and multi-drug resistant bacterial infections, recently revealed promising results from its Phase 1 clinical trials for the drug candidate SPR720. This study focused specifically on...

Continue Reading
Ardagh Metal Packaging's Major Green Notes Pricing Announcement

Updated Category News Views 176

Ardagh Metal Packaging Prices $1,290 Million Senior Secured Green Notes Ardagh Metal Packaging S.A. (AMP) has made a significant announcement regarding the pricing of an issue of $1,290 million in senior secured green notes. This issuance comprises $620 million of 6.250% senior secured green notes due in 2031 at a price of 100%, representing a yield of 6.250%....

Continue Reading
Imperial Petroleum Sees Growth Amid Market Challenges in 2025

Updated Category News Views 162

Introduction to Financial Results IMPERIAL PETROLEUM INC. (NASDAQ: IMPP) has reported its unaudited financial and operating results for the second quarter and the first half of 2025. This ship-owning company specializes in petroleum products, crude oil, and dry bulk seaborne transportation services. The results of this period reflect a strategic approach in navigating the...

Continue Reading
Explore St. Louis Welcomes Brad Dean as New CEO and President

Updated Category News Views 640

Explore St. Louis Welcomes Brad Dean as Its New Leader Explore St. Louis has made an exciting announcement regarding its leadership. After a thorough nationwide search, the organization has appointed Brad Dean as its new President and CEO. This transition marks a pivotal moment for Explore St. Louis as it aims to elevate the tourism and convention industry in the area....

Continue Reading